In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...